Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa

Not Applicable

Completed

• Conditions: Hidradenitis Suppurativa
• Interventions: Behavioral: Written Action Plan; Behavioral: Verbal consultation

• Registration Number: NCT04600375
• Lead Sponsor: University of Arkansas

Brief Summary

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-10-19
• Study First Submitted QC: 2020-10-19
• Study Start: 2020-10-20
• Study First Posted: 2020-10-23
• Primary Completion: 2020-12-07
• Study Completion: 2020-12-07
• Results First Submitted: 2021-11-30
• Status Verified: 2022-02
• Results First Submitted QC: 2022-02-08
• Results First Posted: 2022-04-06
• Last Update Submitted: 2022-04-11
• Last Update Posted: 2022-04-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

• This study will only enroll subjects between the ages of 18-years and 89-years of age.
• Diagnosis of HS by a board-certified dermatologist
• Able to read and comprehend study materials
• No prior exposure to written HS action plans

Exclusion Criteria

• Those who do not fit the inclusion criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental: Written Action Plan	Written Action Plan	INTERVENTION GROUP 1. Survey A 2. Routine clinic visit 3. Verbal consultation AND Written Action Plan 4. Survey C
Verbal Consultation, then Written Action Plan	Verbal consultation	CONTROL GROUP 1. Survey A 2. Routine clinic visit 3. Verbal consultation only 4. Survey B 5. Verbal consultation AND Written Action Plan 6. Survey C
Verbal Consultation, then Written Action Plan	Written Action Plan	CONTROL GROUP 1. Survey A 2. Routine clinic visit 3. Verbal consultation only 4. Survey B 5. Verbal consultation AND Written Action Plan 6. Survey C

Primary Outcome Measures

Name	Time	Method
Visits to High-cost Care Settings [ Time Frame: 1.5 Months ]	Through study completion, an average of 1.5 months	Number of visits to ER, urgent care, or hospitalizations because of HS

Trial Locations

Locations (1)

University of Arkansas for Medical Sciences; 🇺🇸 Little Rock, Arkansas, United States